UCB SA (XBRU:UCB)
€ 189.4 -2.25 (-1.17%) Market Cap: 35.93 Bil Enterprise Value: 38.28 Bil PE Ratio: 157.09 PB Ratio: 4.06 GF Score: 64/100

UCB SA to Acquire Zogenix Inc Capital Markets Call Transcript

Jan 19, 2022 / 01:30PM GMT
Release Date Price: €91.52 (+3.04%)
Antje Witte
UCB SA - Head of IR

Good morning, good afternoon to the call, Capital Market Conference Call by UCB. My name is Antje, Antje Witte, I'm heading Investor Relations at UCB. We'd like to talk to you today about our agreement we did with Zogenix to acquire the company. And before we start with our presentation, I'd like to highlight some details. Please be informed about this important information about the tender offer.

This tender offer as laid out in the presentation and in the press release this morning, has not yet started. This call and the press release are for informational purposes only and are neither an offer to purchase nor a solicitation of an offer to sell any shares of the common stock of Zogenix or any other securities. I kindly ask you to read this slide carefully.

On the next slide, I have to make you aware of our disclaimer and forward-looking statements. This is a traditional disclaimer you find in our presentations. We are talking about future events, potential future events, and we urge you to have a close look to this disclaimer and forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot